Andante

Quick links to important sections

Andante

Selected form

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Andante

Property Description
Active ingredient Zaleplon
Form Oral capsule (Immediate-release)
Pharmacological class Sedative-hypnotic agent (Z-drug)
Common use Short-term treatment of difficulty falling asleep
Origin Synthetic compound

What Type of Medicine is Andante (Zaleplon)?

Andante is a prescription-only medicine whose active component is the substance Zaleplon, which is a synthetic compound. Pharmacologically, it is classified as a sedative-hypnotic agent and is a member of the nonbenzodiazepine pyrazolopyrimidine class. This group is often colloquially known as Z-drugs, along with Zolpidem and Zopiclone. Although Zaleplon interacts with the GABAA receptor complex in the brain, similar to benzodiazepines, its distinct chemical structure and selective binding profile define it as a non-BZD compound. Zaleplon is clinically recognized for its high specificity to the alpha 1 subunit of the GABAA receptor, differentiating its pharmacological profile from less selective sleep aids.


Composition and Form: The Zaleplon Capsule

The medication is a single-ingredient product delivered as an oral dosage form in an immediate-release capsule. The active ingredient, Zaleplon, is combined with pharmaceutical excipients necessary for the solid formulation. A defining feature of Zaleplon's profile is its exceptionally short elimination half-life of approximately one hour. This medicine is designed to exit the body rapidly. This rapid clearance is an inherent characteristic of the drug's composition and is a key factor in its clinical application.


What is the General Purpose of Zaleplon?

The primary purpose of Zaleplon is the short-term treatment of insomnia specifically characterized by difficulty falling asleep. It functions by enhancing the effects of the brain's natural inhibitory neurotransmitter, GABA, thereby quickly quieting the necessary brain activity required to initiate sleep. The characteristic short half-life of Zaleplon ensures a rapid onset of action, giving it the general benefit of facilitating the start of a sleep period. Zaleplon effectively shortens the time it takes to fall asleep in patients with insomnia. This medication has been shown to successfully reduce the latency to persistent sleep.

Regulatory References

  1. DailyMed

What side effects are possible with Andante?

Possible Side Effects and Safety Information

The official safety profile for Andante (Zaleplon) classifies potential adverse reactions based on how often they have been observed in clinical data, as mandated by regulatory authorities. These effects are systematically grouped by the body system they affect, primarily involving the Central Nervous System (CNS) and the Gastrointestinal system.

Classification Examples of Reactions
Common Reactions Headache, somnolence (drowsiness), dizziness, asthenia, and nausea.
Uncommon Reactions Amnesia, hallucinations, paresthesia, and malaise.

Serious adverse reactions are specifically highlighted in regulatory documents. These include the potential for Complex Sleep-Related Behaviors—such as driving or preparing food while not fully awake—and severe Hypersensitivity Reactions like anaphylaxis and angioedema (swelling of the face, tongue, or throat).

Regulatory labels also define safety patterns related to use. The risk of developing physical or psychological dependence increases with the duration and dose of treatment. Additionally, rebound insomnia, a temporary worsening of sleep difficulties, may occur upon cessation of the medicine. The risk of anterograde amnesia is noted, which most often occurs within several hours after ingestion.

Safety restrictions are defined for certain populations and pre-existing conditions. Andante is not recommended for individuals with severe hepatic insufficiency or those diagnosed with severe sleep apnea syndrome or Myasthenia Gravis. Older adults are considered more susceptible to CNS-related adverse effects like dizziness.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Andante (Zaleplon) is officially documented as an exaggeration of the medicine’s central nervous system (CNS) depressant effects. Urgent medical attention is required for any suspected overdose to allow for mandated monitoring and specialized supportive intervention.

Documented Manifestations and Risks

Presentation Type Officially Documented Signs
Mild Cases Drowsiness, mental confusion, lethargy
Serious Cases Ataxia (loss of coordination), hypotonia (reduced muscle tone), hypotension, loss of consciousness
Severe Outcomes Respiratory depression, coma (rarely), death (very rarely)

The official regulatory profile notes that Zaleplon overdose affects the CNS, respiratory, and cardiovascular systems. It is explicitly documented that no specific antidote is known for Zaleplon overdose. Therefore, the required management protocol focuses entirely on observational support.

Required Emergency Actions

In all cases of suspected overdose, immediate and continuous monitoring of vital signs—including respiration, pulse, and blood pressure—must be initiated. General supportive measures must be employed to stabilize the patient and treat documented clinical manifestations. This involves appropriate medical intervention for severe CNS depression and the management of hypotension.

Therapeutic Uses of Andante

What Andante Treats: Main Uses and Benefits

Andante (Zaleplon) is generally used for the short-term symptomatic treatment of insomnia where the main difficulty is falling asleep. It is applied in situations involving certain distressing symptoms, characterized by long sleep latency, which is used for managing symptoms that interfere with daily comfort. This supportive relief contributes to easing the overall symptom load. The medication is relevant in conditions characterized by periods of heightened symptoms, which include sleep onset disturbance and transient insomnia episodes.

The medication is considered relevant in contexts marked by increased discomfort or tension, applied in scenarios where additional management of discomfort is required. The primary benefit for patients may assist with managing symptoms of difficulty falling asleep and supports general well-being during symptomatic phases, especially regarding next-day comfort. This is particularly relevant for patients seeking to maintain functional stability upon waking.


Supportive Facts: Therapeutic Focus

  • Primary Symptom Addressed: Long sleep latency (difficulty falling asleep).
  • Key Therapeutic Context: Short-term assistance with managing difficulty falling asleep.
  • Core Patient Benefit: Supports general well-being by easing the overall symptom load and contributing to next-day comfort.

Eligibility and Restrictions for Use

Andante (zaleplon) is a sedative-hypnotic medication primarily prescribed for the short-term treatment of insomnia in adults who have difficulty falling asleep.

Who Should Not Use Andante?

Certain conditions and populations prohibit the use of Andante due to potential risks. You should not take this medication if you:

  • Have known severe liver impairment.
  • Have had a severe allergic reaction or hypersensitivity to zaleplon or any of its ingredients.
  • Have experienced complex sleep behaviors (such as sleep-driving, sleep-walking, or cooking while not fully awake) after taking Andante or similar medicines.

Precautions and Special Populations

Caution is advised and dose adjustment may be necessary for patients with:

Condition/Population Precaution/Recommendation
Severe Renal Impairment Not adequately studied; use with caution.
Mild to Moderate Liver Impairment A lower starting dose (e.g., 5 mg) is generally recommended.
Elderly Patients (65 and older) May be more sensitive to side effects (e.g., dizziness, confusion, or falling); a lower initial dose is typically advised.
Depression or Mental Illness Use with caution, as it may worsen symptoms, including suicidal ideation.
Lung Disease/Breathing Problems Use with caution due to the risk of respiratory depression.
History of Substance Abuse Use with caution due to the potential for dependence or misuse.
Pregnancy/Breastfeeding Not recommended; consult a healthcare provider to weigh risks and benefits.

Andante is not approved for use in the pediatric population (children and adolescents).

What should I know about interactions with other medicines?

Andante (Zaleplon) has officially documented interactions that modify its concentration in the body or enhance its effects on the central nervous system.

Drug and Product Interactions

Classification Interacting Entity / Class Official Regulatory Statement
Increased Exposure Cimetidine Increases Zaleplon plasma concentrations by approximately 85% by inhibiting its metabolism (aldehyde oxidase and CYP3A4).
Decreased Exposure Rifampicin Causes a substantial four-fold reduction in Zaleplon plasma concentration due to its strong induction of the CYP3A4 enzyme. Other CYP3A4 inducers (e.g., Carbamazepine, Phenobarbitone) may also reduce efficacy.
Pharmacodynamic Alcohol (Ethanol) Co-administration is formally not recommended due to the potential for enhancement of the central sedative effect.
Pharmacodynamic CNS Depressants Co-administration with classes such as antipsychotics, narcotic analgesics, or sedative antihistamines may result in additive central sedation.
Food Interaction High-Fat/Heavy Meal Administration with a heavy meal delays absorption and reduces the maximum plasma concentration by about 35%.

Population-Specific Constraint

Use in patients with Severe Hepatic Impairment is not recommended. This constraint is due to significantly reduced drug clearance, which leads to a marked increase in Zaleplon's exposure in this population.

Mechanism of Action

Andante's mechanism of action is characterized by functional selectivity, augmenting the brain's natural inhibitory pathways, which results in the modulation of CNS excitability.

The drug acts as a Positive Allosteric Modulator (PAM), specifically targeting the alpha1 subunit of the GABA A receptor complex. This selective binding enhances the inhibitory effects of the neurotransmitter GABA, increasing the frequency with which the receptor's chloride ion ( Cl^-) channel opens. This leads to Cl^- influx and neuronal hyperpolarization (a negative shift in voltage), thereby reducing the action potential firing rate of the cell.

This cellular cascade translates into the systemic reduction of activity within CNS arousal centers. The resulting predictable adjustment in systemic activity induces the physiological state of central sedation. The mechanism's functional duration is constrained by the drug's rapid clearance, limiting the physiological modulation primarily to the initial phase of CNS quieting.

Dosage and Administration Information

Andante (Zaleplon) is administered as an oral immediate-release capsule for the short-term treatment of difficulty falling asleep. The standard recommended dose for non-elderly adults is 10 mg once daily, taken immediately before going to bed or after a patient has gone to bed and is experiencing difficulty falling asleep.

A critical instruction for administration is that the dose must be taken only when the patient has the allowance for 7 to 8 hours of uninterrupted sleep. Zaleplon is indicated for short-term treatment, and the duration of use should be as brief as possible, typically not exceeding two to five weeks depending on the guidance being followed. Patients should not take a second dose within the same night.

Dose adjustments are specified for certain populations. Older adults (geriatric patients) are typically recommended a lower starting dose of 5 mg once daily. The 5 mg dose is also required for patients with mild-to-moderate liver impairment and for those concomitantly taking cimetidine, due to metabolic considerations. Administration should be separated from heavy, high-fat meals, as food can delay the drug’s absorption rate. No dose adjustment is generally necessary for mild-to-moderate kidney impairment.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Andante (Zaleplon)


Evidence for Short-Term Treatment of Difficulty Falling Asleep

The clinical research for Andante (Zaleplon) has been primarily used in research exploring how symptoms change over time in people experiencing insomnia where the main difficulty is falling asleep, a condition often described as long sleep latency. The foundation of this evidence relies on short-term, randomized controlled trials (RCTs). These trials typically compare Zaleplon to a placebo, which is an inactive pill, to monitor patterns of change measured during the study period. Studies often examine outcomes describing episodic or acute changes in sleep patterns.

Researchers examined specific, measurable metrics related to initiating sleep. This included objective measures recorded in sleep laboratories, such as the time taken to reach persistent sleep, and patient-reported outcomes describing perceived discomfort. Studies report how symptoms evolved in the observed populations, and these findings describe patterns observed in the studies where studies measured a difference in the time to sleep onset between individuals who received Zaleplon and those who received the placebo over short periods of use. However, the reported outcomes were primarily focused on the time needed to fall asleep; findings were mixed regarding patterns of change in total sleep duration or the number of times people woke up during the night.


Research Structure and Measured Outcomes

Research on Andante was evaluated in studies focusing on outcomes related to systemic or functional imbalance that affects sleep initiation. In addition to objective measures, trials also monitored patient-reported outcomes describing perceived discomfort. A key focus of the research was observed in examining next-day effects, such as residual grogginess or difficulty concentrating. This research provides insight into short-term changes in cognitive performance following the use of the medicine. Some studies noted patterns of change in next-day functioning measurements shortly after waking, which researchers sometimes relate to the medicine's short half-life.


Long-Term Research and Study Duration

Andante was studied for short-term symptom changes in conditions characterized by acute or disruptive episodes. The existing body of RCTs typically monitored patient responses over defined time intervals that do not exceed six weeks. This follow-up duration is consistent with the medicine's focus on short-term research. Consequently, there is limited information for long-term outcomes. The available evidence provides context but not individual predictions regarding outcomes that extend past the standard short-term study duration examined in the original research, meaning the long-term effects are not fully established.

Frequently Asked Questions (FAQ)

Common questions about Andante (FAQ)

Q: How quickly does Andante typically start to work?

A: Andante is designed to have a rapid onset of action. Official information states that the highest concentration of the drug in the blood is usually reached about one hour after the capsule is taken. This characteristic is described in clinical pharmacology studies as contributing to its potential to reduce the time needed to fall asleep.

Q: How long does the effect of Andante usually last?

A: Andante is known for its very short duration of action, which is a key characteristic of the drug. The active component is quickly cleared from the body, having an approximate half-life of just one hour. Because of this, its effects on promoting sleep are generally limited to the initial hours of the night, aligning with its purpose for difficulty with sleep onset.

Q: Can Andante be taken with food, or should it be on an empty stomach?

A: Official instructions advise against taking the medicine with or immediately following a heavy, high-fat meal. Administration with a heavy meal can delay the medicine's absorption and reduce its concentration in the body. This delay in absorption could potentially lessen or postpone the drug’s intended effect on sleep onset.

Q: Is it normal to feel groggy the morning after taking Andante?

A: Drowsiness or feeling less alert the day after use, sometimes called residual somnolence, is an officially reported side effect. The possibility of experiencing next-day effects is listed in regulatory documents and may depend on an individual's response to the medicine.

Q: Can Andante cause changes in mood or behavior?

A: Yes, regulatory documents describe the potential for abnormal thinking and changes in behavior. These changes may include symptoms such as agitation, aggression, hallucinations, and confusion. Furthermore, the potential for worsening of pre-existing depression, including the emergence of suicidal thinking, is noted in warnings.

Q: Are there any common over-the-counter medications that interact with Andante?

A: Andante is known to have additive effects when taken with other medications that slow down the Central Nervous System (CNS). This broad class includes certain non-prescription medicines, such as specific antihistamines found in some cold, allergy, or over-the-counter sleep relief products. Taking them together may increase the risk of central sedation, such as increased dizziness or drowsiness.

Q: What is the difference between Andante and other common sleep aids?

A: Andante belongs to the class of non-benzodiazepine sedative-hypnotics, often referred to as Z-drugs. Its distinct chemical structure and selective action on certain brain receptors set it apart from older hypnotic classes, such as traditional benzodiazepines or simple antihistamine-based sleep aids.

Q: Is Andante considered a controlled substance?

A: Yes, Andante (Zaleplon) is classified as a controlled substance by regulatory authorities. This classification is due to the official recognition of its potential for dependence, abuse, or misuse.

Q: Is Andante the same as zolpidem or zaleplon?

A: Andante is the brand name for the active ingredient zaleplon. Both zaleplon and zolpidem belong to the same pharmacological class of Z-drugs. However, they are chemically distinct substances with different properties, including a different elimination half-life.

Q: What does the research say about the effectiveness of Andante for long-term use?

A: The clinical trials that support the use of Andante primarily focus on short-term treatment, generally over a period not exceeding two to five weeks. Because of this focus, regulatory documents state that there is limited information available on the outcomes or safety profile for use that extends past this standard short-term study duration.

Q: Are there different strengths or formulations of Andante available?

A: According to the official product information, Andante is supplied as an oral, immediate-release capsule. The two dose strengths typically mentioned in regulatory documents are the 5 mg and 10 mg capsules.

Q: Does Andante interact with herbal supplements like St. John's Wort or melatonin?

A: Official information details interactions with strong CYP3A4 inducers, which are substances that speed up how quickly the body processes the drug. St. John's Wort is a known CYP3A4 inducer and may potentially lead to a reduction in the concentration and resulting effectiveness of Andante. There is no specific regulatory statement regarding melatonin.

Q: Why do some people experience a 'metallic taste' after taking Andante?

A: A change in the sense of taste, sometimes referred to as taste perversion, is noted in the official safety data as a possible adverse reaction. This generalized description of a change in sensation may encompass reports of metallic or other unusual tastes from users.

Q: Is Andante approved for jet lag?

A: The approved use for Andante is specifically the short-term treatment of insomnia when the main difficulty is falling asleep. Regulatory documents do not list jet lag as an approved indication for this medicine.

Q: Do foods high in fat impact how Andante works?

A: Taking Andante with a meal that is heavy or high in fat delays the rate at which the drug is absorbed into the bloodstream. This change in absorption rate can reduce the maximum concentration of the drug and can result in a lessened or delayed effect on sleep onset.

Q: Does Andante work by making you feel sleepy, or by regulating sleep cycles?

A: The medicine works by enhancing the effects of a natural brain chemical called GABA, which acts to quiet brain activity. This mechanism is intended to result in the quieting of brain activity to help facilitate sleep initiation. Studies have indicated that the drug's short action profile means its effects on sleep maintenance or the overall structure of sleep cycles are minimal or absent.

Q: Are there documented cases of allergic reactions to Andante?

A: Yes, official warnings highlight the potential for severe hypersensitivity reactions. These serious reactions can include anaphylaxis (a severe, life-threatening allergic reaction) and angioedema (swelling of the face, tongue, or throat) which are noted in regulatory documents.

Q: Is Andante known to cause confusion, especially in older adults?

A: Older adults may be more sensitive to side effects that affect the central nervous system. Official information specifically notes that side effects such as confusion, dizziness, and falling are more likely to be reported in the elderly population.

Q: Is it true that Andante works differently for men and women?

A: Pharmacokinetic studies have not demonstrated any differences in the drug's metabolism or exposure between men and women that are considered clinically significant. Regulatory documents indicate that the standard starting dose is generally the same for adult men and women who are not elderly or affected by certain health conditions.

Q: Can taking Andante with specific juices, like grapefruit juice, be dangerous?

A: Grapefruit juice is known to interfere with certain enzymes (CYP3A4) that the body uses to process medications. Because Andante is partially metabolized by this enzyme, consuming grapefruit juice could potentially increase the drug's concentration in the body by interfering with its metabolism. This could theoretically enhance the drug’s effects or increase the potential for adverse reactions.

Q: Is Andante prescribed for anxiety in addition to sleep problems?

A: Andante is approved for the short-term treatment of insomnia, specifically to help with difficulty falling asleep. It is not approved or indicated for the treatment of anxiety disorders or psychotic illnesses.

Q: Do people who take Andante report any unusual dreams?

A: Official regulatory documents list 'nightmares,' 'abnormal dreams,' and 'hallucinations' as psychiatric or paradoxical reactions that have been reported in association with the use of Z-drugs.

Q: Can Andante cause problems with memory?

A: Official warnings note the potential for memory problems, specifically a type called anterograde amnesia. This condition involves difficulty remembering events that occur during the hours immediately after the drug is ingested. The official instruction to ensure a full 7-8 hours of sleep allowance is designed, in part, to help reduce this potential risk.

Q: Why is the active ingredient in Andante sometimes referred to as Z-drug?

A: The active ingredient, zaleplon, is a non-benzodiazepine sedative-hypnotic. This specific class of hypnotics is often informally grouped together and called 'Z-drugs' because the common names of the active ingredients, such as zaleplon and zolpidem, all begin with the letter Z.

Q: Is it necessary to have a full night's sleep planned after taking Andante?

A: Yes, official instructions explicitly state that the medicine should only be taken when you have the allowance for a full 7 to 8 hours of uninterrupted sleep. This instruction is important to minimize the potential for experiencing next-day side effects, such as residual drowsiness and impaired memory.

Q: Does taking Andante affect driving or operating machinery?

A: Due to the potential for side effects like residual drowsiness, dizziness, and impaired coordination, official warnings caution against engaging in hazardous activities. Activities requiring full mental alertness, such as driving or operating machinery, are generally advised against until the individual is aware of how the medicine may affect their functioning.

Q: Does Andante lose its effect over time if used regularly?

A: Official documents indicate the medicine is approved only for short-term use due to the research being focused on this duration. While efficacy has been demonstrated for short periods, there is insufficient evidence from clinical trials to fully characterize the development of tolerance, or loss of effect, when used long-term.

Q: Does the time of day matter for when other non-interacting medications are taken with Andante?

A: The specific timing of administration is critical to the use profile of Andante. It must be taken immediately before bedtime, and only when a full 7–8 hours of sleep is planned. This timing is essential to ensure it is cleared from the body by the morning, which helps prevent accidental interactions with daytime medications that may also cause CNS effects.

How should Andante be stored and disposed of?

How to Store and Dispose of Andante

Required Storage Conditions

Andante capsules must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F), with permitted excursions up to 30 C. The medication must be kept in a light-resistant container and protected from light and excess moisture, away from the bathroom. As a controlled substance, Andante must be stored securely out of the reach and sight of children to prevent accidental ingestion or misuse.

Official Disposal Rules

Disposal of unused or expired Andante should primarily be conducted through a formal drug take-back program. If this option is not available, the capsules must be mixed with an unappealing substance, placed in a sealed bag, and disposed of in the household trash. This medication is not on the official list for flushing down a toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Andante found in:

A-Z Index: